Administrative Core

Information

  • Research Project
  • 10270396
  • ApplicationId
    10270396
  • Core Project Number
    P01CA254849
  • Full Project Number
    1P01CA254849-01A1
  • Serial Number
    254849
  • FOA Number
    PAR-20-077
  • Sub Project Id
    5979
  • Project Start Date
    9/16/2021 - 3 years ago
  • Project End Date
    7/31/2026 - a year from now
  • Program Officer Name
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/16/2021 - 3 years ago
Organizations

Administrative Core

Abstract Integrating advanced engineering tools and approaches into immunotherapy development projects holds the potential to improve the efficiency of the pre-clinical therapy development pipeline. Developing a robust Immuno- engineering Translation Accelerator (ITA) is a strategic goal for this PPG that stands alongside the scientific goals of the Projects. The Administrative Core will provide overall leadership and administrative support to this PPG in furtherance of the PPG?s scientific goals as well as the broader goal to establish a transformational ITA. The Core will facilitate weekly meetings and semi-annual workshops, promote integration of the PPG projects, support translational activities that emerge from this PPG, and build a collaborative and innovative cancer immuno-engineering community at the University of Minnesota. The Administrative Core will be led by MPIs David Odde (Biomedical Engineer), David Masopust (Cancer Immunologist), and David Largaespada (Genome Engineer) with support from Paolo Provenzano (Biomedical Engineer), Ingunn Stromness (Cancer Immunologist), and Branden Moriarity (Genome Engineer). The work of the Administrative Core will be facilitated by Program Manager Bo Connelly. To facilitate the broad goals of this PPG, the administrative core will implement the following specific aims: Aim 1 ? Provide strong and consistent leadership and management that maximizes PPG impact. Aim 2 ? Evaluate and facilitate scientific progress. Aim 3 ? Build a collaborative, supportive, and innovative cancer immune bioengineering community. Aim 4 ? Support and accelerate clinical translational through the creation of an Immuno-Engineering Translation Accelerator (ITA).

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    P01
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
    156346
  • Indirect Cost Amount
    85990
  • Total Cost
  • Sub Project Total Cost
    242336
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NCI:242336\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF MINNESOTA
  • Organization Department
  • Organization DUNS
    555917996
  • Organization City
    MINNEAPOLIS
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    554552070
  • Organization District
    UNITED STATES